G790A_AttB_ACE2-miRFP670_IRES_mCherry-H2A-P2A-PuroR
(Plasmid
#237440)
-
PurposePlasmid for strong human ACE2 expression from the Bxb1 landing pad, with a C-terminal miRFP670 fusion includes IRES-driven mCherry-H2A and P2A-linked PuroR for selection and visualization.
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 237440 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backboneCustom
- Total vector size (bp) 9121
-
Vector typeMammalian Expression, Synthetic Biology ; Promotorless Bxb1 DNA recombination
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameACE2
-
Alt nameAngiotensin-converting enzyme 2
-
Alt namehACE2
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2445
-
Entrez GeneACE2 (a.k.a. ACEH)
-
Tags
/ Fusion Proteins
- miRFP670 (C terminal on insert)
- mCherry (C terminal on backbone)
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer AACGACGGCCAGTGAATTG
- 3′ sequencing primer CGTTACTGGCCGAAGCCGC
- (Common Sequencing Primers)
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
G790A_AttB_ACE2-miRFP670_IRES_mCherry-H2A-P2A-PuroR was a gift from Kenneth Matreyek (Addgene plasmid # 237440 ; http://n2t.net/addgene:237440 ; RRID:Addgene_237440) -
For your References section:
Kozak sequence libraries for systematically characterizing transgenes across expression levels. Shukla N, Kamath ND, Snell JC, Bruchez AM, Matreyek KA. Nucleic Acids Res. 2026 Jul 17;54(14):gkag728. doi: 10.1093/nar/gkag728. 10.1093/nar/gkag728 PubMed 42475684